NAMSA’s Post

Explore your market's potential with NAMSA's Market Research! 🌐💡 Seeking insights from physicians for your product or looking to better understand client preferences? NAMSA offers extensive market research, with over 100,000 participants and decades of experience, conducting 30,000+ interviews yearly in all MedTech areas. Why Choose NAMSA? 🚀 Extensive Reach: Our 100,000+ participant database ensures diverse and comprehensive insights 💼 Expertise Matters: With decades of experience, we design studies that truly uncover the pulse of your market 🌍 Global Impact: Operating across all MedTech therapeutic areas, we provide insights with a global perspective Ready to Navigate Your Market Landscape? Learn more today! 📊👥 https://lnkd.in/dfPhAqqg #MarketResearch #MarketInsights #MedTech #NAMSA #SUAZIO #NAMSAKnows

🔈NHS Launches New RSV Vaccination Program ➡️ The NHS has launched a new vaccination program targeting Respiratory Syncytial Virus (#RSV) to protect pregnant women and older adults. Starting September 1, 2024 the vaccine will be offered to women from 28 weeks of pregnancy and adults turning 75.   ➡️ This initiative aims to prevent thousands of hospital admissions, easing NHS pressures during winter. RSV can cause severe illness in babies, older adults, and those with weakened immune systems. Health officials emphasize the importance of vaccination to protect vulnerable populations and manage #NHS capacity. Last winter, an average of 146 young children were hospitalized daily due to RSV.   ➡️ Starting September 1, the NHS is rolling out a groundbreaking #vaccination program against respiratory syncytial virus (RSV) for pregnant women and older adults. This initiative aims to protect the most vulnerable and ease pressures on the NHS during the winter months.   ➕ Find more detail on Official webpage of NHS   🔔 Meet me at the Swiss MedTech 2024 event on September 04 in Biel, CH https://lnkd.in/dnEDWzGR

📈 Europe’s fastest-growing companies, Physidia rewarded for 2024 🚀 This year, again, PHYSIDIA is part of the 1000 Europe’s fastest-growing companies, edited by the Financial Times. The FT 1000: Europe’s Fastest Growing Companies is a list of the top 1,000 companies in Europe that have achieved the highest percentage growth in revenues between 2019 and 2022. To consult the ranking, click on the link:  https://lnkd.in/dy2jZ6kR Also, Physidia is part of the Champions of Growth in France, a ranking published by the magazine Les Echos. This ranking rewards the 500 most dynamic and fastest growing French companies in the period 2019 – 2022. Physidia is ranked 100th in the general ranking, and 2nd in the health and medical-social sector. To consult the ranking, click on the link :https://lnkd.in/ev6_iTC7 #FastestGrowingCompanies #Santé #Innovation #PatientCentric #makepeopleslivesbetter #GrowthChampions #Healthcare #Innovation #PatientCentric

Unlock Patient Insights with MHN's Patients Panel! 📊 Are you an insight agency supporting pharma brands? You can look no further than MHN's specialized panel. Our database is brimming with patients eager to share experiences and provide invaluable feedback for your projects. Contact MHN today to harness expert qual logistics for transformative research! #QualitativeResearch #QuantitativeResearch #MHN #Insights #PatientPanel #HealthcareResearch #ExpertFeedback 🩲💡🔍

Unlock Patient Insights with MHN's Patients Panel! 📊 Are you an insight agency supporting pharma brands? You can look no further than MHN's specialized panel. Our database is brimming with patients eager to share experiences and provide invaluable feedback for your projects. Contact MHN today to harness expert qual logistics for transformative research! #QualitativeResearch #QuantitativeResearch #MHN #Insights #PatientPanel #HealthcareResearch #ExpertFeedback 🩲💡🔍

ISPOR has released its 2024-2025 Top 10 HEOR Trends Report. This is the fifth publication for this initiative that is now published as a biennial report. Real-world evidence (RWE) appears again as the #1 trend, followed by Drug Pricing and Artificial Intelligence. Although much has been done in LATAM countries to develop these concepts and the science behind them during the last 25-30 years, I realize how much room there still exists for improvement! At Ceibo Health, we'd love to collaborate with you to take market access and HEOR to the next level within your organization. More information on this report at ispor.org #latam #marketaccess #healthcareconsulting #healtheconomics

🔬Medlab 2024 Highlights and Market Insights Our key takeaway from Medlab 2024 is that the Asian market is hungry for our products, offering potentially valuable business opportunities in the upcoming year. We are excited to explore these opportunities and bring our solutions to new markets. Here are some highlights: 📈Emerging Markets: We observed a significant buzz and enthusiasm in Thailand and other regions in the ASEAN Region. The willingness of the people to improve their life situation presents numerous opportunities for the medical device industry. 🚛 Excited Distributors: The ASEAN Region is undoubtedly a distributor-driven market. We engaged with many distributors who are eager to see our products on the market, showcasing the high demand and potential for our offerings. ⭐️ Breakthrough innovation: Our products, Glucowave and Touchwave, attracted significant interest at Medlab 2024. We received positive feedback, particularly about Glucowave's potential to make a real impact in combating the diabetes endemic in countries like the Philippines and Indonesia. 🙏 A big thank you to all the organizers (@Bernice, @Norbert @Yumai) speakers, and participants for making Medlab 2024 a success. We look forward to leveraging these insights and driving our global recognition. 🙏 Norbert Bak Bernice Jenvdhanaken Miłosz Mazurkiewicz Łukasz Pytlarczyk Zenon Szczepaniak Robert Gromada Marcin Malinowski Felix Kriegeskotte Michał Holz Michał KniołaSlawomir Kosciak Ewa Mościcka Wojciech Iwaniuk Riccardo Falduto CORMAY DIAGNOSTICS Mercator Medical S.A. Cyberbone Medical Inventi S.A. HigoSense #Medlab2024 #MedicalInnovation #Medisensonic #Healthcare #Diagnostics #Networking #AsianMarket #BusinessOpportunities

On March 5-6 2024, the annual health conference was held in Jerusalem and I as CEO of PharmaPrime, thanks to ITA - Italian Trade Agency, had the honor and privilege to participate in presenting the services that Pharmaprime offers and proposes to Companies having the interest and health of patients at heart. Pharmaprime has always been committed to creating innovative projects by combining technologies with digital health solutions to achieve the best results in therapeutics. MIXiii Health-Tech.IL showcase is the annual and international event held this year in Jerusalem where Life Science and Health Tech industries can come together to share new technologies and new discoveries in the field of health. The goal is to unite the Israeli tech ecosystem with other countries around the world to provide solutions and support at all levels and thus integrate the various sectors of industry with multinational R&D centers, Startups, Academic Institutions, Innovation Centers, hospitals, and the Government. This event is a showcase of the world of people's health and well-being and Research, effectively creating a network between the various sectors to improve and enhance services for the health of citizens. #healthcare #digitalhealth #Mixiii

It was my pleasure to share insights and to discuss #innovation and how to do more with less #healthcare #genomics #clinicaltrials

Opening remarks written by Eran Harary for the Israel HealthTech Digest by 8400: "Dear Partners, Colleagues, and Friends,   As Passover approaches, let us reflect on our journey, where challenges serve as catalysts for growth, and innovation paves the way to a brighter future for all. Passover beautifully illustrates the power of community in transcending adversity. Teva's recent initiative to identify innovative technologies with the potential to strengthen Israel's mental health system, undertaken in collaboration with 8400, serves as a shining example of these two organizations' dedication to accelerating global cure by taking unique and creative approaches (read more about the initative HERE). This initiative exemplifies resilience and effectiveness in fostering positive change. Fueled by brainpower, determination, and scientific acumen, Israel is emerging from adversity with newfound strength.   As members of the healthcare and biotech ecosystem, it is our shared responsibility to harness the collective power of our ecosystems to promote health universally. Let's bridge across boundaries to create meaningful changes that reach and benefit people across the globe.   Eran Harary, MD, SVP Global Clinical Development, Teva Pharmaceuticals; 8400 Network Member" For the full issue: https://lnkd.in/dt6r6y-c]